ArticleJournal of endocrinological investigation2026
Vitamin D receptor expression in human adrenal medulla and pheochromocytoma cells.
Article in Journal of endocrinological investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeWe aimed to elucidate the expression of VDR (vitamin D receptor) in human adrenal medulla and pheochromocytoma cells and to investigate the potential associations between VDR and the clinicopathological characteristics of pheochromocytoma.
methodsThe expression of VDR at the mRNA level in FFPE (Formalin-Fixed Paraffin Embedded) tissues from 31 pheochromocytomas, 4 adrenal cortex and 4 adrenal medulla was assessed via highly sensitive digital PCR. For pheochromocytoma patients, the clinical and histopathological features were retrospectively assessed.
resultsVDR mRNA expression in adrenal medulla and pheochromocytoma cells was compared to the expression in the adrenal cortex, which was set at 1.0. The median VDR mRNA expression in pheochromocytoma samples was lower than that in both unaltered medulla and cortex. No statistically significant correlations were detected between VDR mRNA expression in pheochromocytomas and most of the clinical parameters. The VDR expression level did not significantly correlate with the vitamin D concentration in the patients’ serum. However, VDR expression in tumors was negatively associated with somatostatin receptor 2 (SSTR2) levels, with the confounding influence of sex and the interaction with elevated 3-methoxytyramine concentrations.
conclusionOur study is the first to characterize the expression of the vitamin D receptor (VDR) in both the intact adrenal medulla and pheochromocytoma cells. The highest median VDR expression was observed in the adrenal cortex, followed by intermediate levels in the adrenal medulla, and the lowest expression in pheochromocytoma cells. However, further studies are needed to clarify the relationship between vitamin D and catecholaminergic cells.
Indexed as
Identifiers
41706417What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.